NEUSERA
ETIFOXINE HYDROCHLORIDE
What it does
Etifoxine is a medication that helps reduce anxiety and improve mood.
Commonly used for: anxiety disorders, stress-related conditions
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: South African Health Products Regulatory Authority · fetched 2026-08-27 10:17:23 · updated 2026-09-16 04:01:14
About this medicine
Etifoxine is a medication that helps reduce anxiety and improve mood.
What it treats
- anxiety disorders
- stress-related conditions
How it works
Etifoxine works by calming the brain and helping to improve feelings of anxiety.
Who it's for
It is for adults experiencing anxiety or stress.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: etifoxine
BNF-referencedEtifoxine is an anxiolytic agent primarily used for the treatment of anxiety disorders. It is known for its neuroprotective properties and is considered to enhance the action of GABA, which is a major inhibitory neurotransmitter in the central nervous system. This drug may be utilized in various clinical settings to manage anxiety-related symptoms and improve patient well-being.
Indications
- Anxiety disorders
- Generalized anxiety disorder
- Panic disorder
- Acute stress reactions
Dosage
Children: Refer to the BNF for Children for paediatric dosing recommendations as they are not specified here.
Adults: The usual adult dosage is 100 mg to 200 mg taken orally, divided into two or three doses per day.
Mechanism of action
Etifoxine acts by enhancing the action of GABA at the GABA-A receptor, leading to increased chloride ion influx and hyperpolarization of neuronal membranes. It is also thought to modulate neurosteroid levels, which contribute to its anxiolytic effects, promoting a calming effect without the sedative properties typically associated with benzodiazepines.
Pharmacodynamics
Etifoxine exhibits anxiolytic effects through its action on GABA receptors, leading to reduced neuronal excitability. Its neuroprotective properties may result from its ability to modulate neurosteroid levels and influence brain-derived neurotrophic factor (BDNF), which is important for neuronal survival and plasticity.
Pharmacokinetics
Etifoxine is well-absorbed following oral administration, with peak plasma concentrations typically reached within a few hours. It is metabolized in the liver, with various pathways leading to the formation of active metabolites. The drug has a moderate half-life, allowing for once or twice daily dosing. Elimination is primarily via the kidneys.
Contra-indications
- Hypersensitivity to etifoxine or any of its components
- Severe hepatic impairment
Adverse effects
- Drowsiness
- Fatigue
- Dizziness
- Nausea
- Skin rash
- Gastrointestinal disturbances
Interactions
- Caution is advised when used with central nervous system depressants
- May enhance the effects of alcohol
Precautions
- Use with caution in patients with a history of liver disease
- Monitor for signs of sedation or excessive drowsiness
Pregnancy
There is limited data on the use of etifoxine in pregnancy. It should only be used if the potential benefit justifies the potential risk to the fetus.
Breast-feeding
It is not known whether etifoxine is excreted in human milk. Caution should be exercised when administering to nursing mothers.
Storage
Store at room temperature, away from moisture and light. Keep out of reach of children.
Formulations
- Tablets
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Molecular reference: etifoxine
PubChem CID 135413553Molecular formula: C17H17ClN2O
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.